Impact of a fermented dairy protein with prebiotic fiber on gastrointestinal complaints in athletes
Effect of a Fermented Whey and Fiber Supplement on Digestive Comfort of Recreational Athletes With and Without GI Complaints
This study is testing if a special dairy protein with added fiber can help athletes with stomach issues feel better and improve their overall health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 114 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | Arizona State University Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Trial ID | NCT06946017 on ClinicalTrials.gov |
What this trial studies
This project investigates the effects of a fermented dairy protein with prebiotic fiber supplement on gastrointestinal (GI) complaints and overall well-being in athletes. It consists of two parts: the first part examines carbohydrate malabsorption in athletes without self-reported GI issues through a randomized double-blind crossover design, while the second part focuses on athletes with GI complaints using a randomized double-blind parallel design. Both parts include standardized exercise tests and aim to assess changes in gut microbiota, immune markers, and overall health. The study is designed to provide insights into the relationship between gut health and athletic performance.
Who should consider this trial
Good fit: Ideal candidates are healthy men and women aged 18-50 who are recreational or competitive athletes exercising at least twice a week.
Not a fit: Patients who do not meet the inclusion criteria or have moderate GI complaints may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved digestive health and quality of life for athletes experiencing GI complaints.
How similar studies have performed: Previous studies have suggested positive outcomes with similar approaches, indicating potential for success in this investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Aside from having participants fitting the inclusion and exclusion criteria below, potential participants will be screened using the gastrointestinal symptom rating scale (GSRS). Based on the outcome they will be assigned to the Part I (i.e. no self-reported GI tract issues (GSRS questionnaire score GI complaints, based on GSRS screening with all items scored \<4 (severe) and a total GSRS score ≤25), or Part II (i.e. Severe self-reported GI tract issues (GSRS questionnaire score GI complaints, based on GSRS screening with at least one item scored ≥4 (severe) and a total GSRS score ≥30). If they don't fit these criteria (i.e., having a GSRS score ranging from 26-29) they will be excluded from participation. Inclusion Criteria: * Healthy subjects living in the Phoenix area in AZ, USA during the study * Women/Men aged between 18-50 years (50-50%) * Recreational competitive and non-competitive athletes (exercise at least 2x per week with a minimal total duration of 2 hours/week) * BMI value between ≥18.5 and ≤ 30 kg/m2 * No physical limitations due to an injury (i.e., able to perform all activities associated with daily living and exercise in an independent manner). * Willing to slightly increase their energy intake via a supplement during the study period on daily basis in the morning before breakfast. * Willing and comfortable to perform multiple physical (stress) tests on a treadmill during the study. * Participants without any contraindications when scoring the Physical Activity Readiness Questionnaire (PAR-Q+). * Written informed consent * For part I: Self-perceived lactose intolerance, and/or omission of dairy products, and/or identifying as Hispanic/Latino or Asian * For part I: Determined to be lactase non-persistent (LNP) CC genotype by qPCR, and/or positive lactose intolerance test (\>20ppm increase from baseline when 25g of lactose administered) Exclusion Criteria: * Users of (sport) supplements containing probiotics and/or prebiotics and those unwilling to temporarily stop use of these supplements at least 3 weeks prior to start of the intervention * Women who plan to start or stop the use of contraceptives before or during study period * Women that have additional or worse GI symptoms during their period that can be classified as severe * Smoking * Clinical lactose intolerance * Clinical or self-perceived milk protein allergy * Diagnosed GI tract disorders or diseases * Musculoskeletal disorders * Diagnosed metabolic disorders (such as diabetes) * Use of any medications known to affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications). * Chronic use of gastric acid suppressing medication or anti-coagulants * Chronic use of anti-inflammatory medication * Use of antibiotics the past 0-6 months * Blood donation in the past 2 months * (Intending to become) Pregnant/lactating women * Significant changes in body weight during the past 4 weeks (i.e., due to reduction of body weight through limiting caloric intake, illness,) * Athletes should not aim to lose bodyweight by reducing energy intake during the study * For Part I: A hydrogen breath peak of less than 20 ppm over baseline during a lactose tolerance test
Where this trial is running
Phoenix, Arizona
- ASU Health Futures Center — Phoenix, Arizona, United States (Recruiting)
Study contacts
- Study coordinator: Floris C Wardenaar, PhD
- Email: Floris.wardenaar@asu.edu
- Phone: 602-543-1853
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.